Peer Review reports
From: Inclusion of phase III clinical trial costs in health economic evaluations
| Original Submission | ||
|---|---|---|
| 13 Apr 2024 | Submitted | Original manuscript |
| 19 Apr 2024 | Author responded | Author comments - Afschin Gandjour |
| Resubmission - Version 2 | ||
| 19 Apr 2024 | Submitted | Manuscript version 2 |
| 15 May 2024 | Reviewed | Reviewer Report |
| 13 Jun 2024 | Reviewed | Reviewer Report - George Miller |
| 29 Aug 2024 | Author responded | Author comments - Afschin Gandjour |
| Resubmission - Version 3 | ||
| 29 Aug 2024 | Submitted | Manuscript version 3 |
| 20 Sep 2024 | Reviewed | Reviewer Report - George Miller |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 23 Sep 2024 | Editorially accepted | |
| 1 Oct 2024 | Article published | 10.1186/s12913-024-11638-0 |
You can find further information about peer review here.